Mark A. Gales

527 total citations
24 papers, 352 citations indexed

About

Mark A. Gales is a scholar working on Infectious Diseases, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mark A. Gales has authored 24 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Surgery and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mark A. Gales's work include Blood disorders and treatments (2 papers), Potassium and Related Disorders (2 papers) and Analytical Methods in Pharmaceuticals (2 papers). Mark A. Gales is often cited by papers focused on Blood disorders and treatments (2 papers), Potassium and Related Disorders (2 papers) and Analytical Methods in Pharmaceuticals (2 papers). Mark A. Gales collaborates with scholars based in United States. Mark A. Gales's co-authors include Barry J Gales, Dennis F. Thompson, Cheri K. Walker, Jennifer Lê, Edna Patatanian and Martin Dyer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Annals of Pharmacotherapy.

In The Last Decade

Mark A. Gales

24 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Gales United States	11	68	64	59	49	46	24	352
Che-Chen Lin Taiwan	12	50 0.7×	29 0.5×	75 1.3×	21 0.4×	25 0.5×	18	350
Nicolas Engrand France	10	86 1.3×	70 1.1×	48 0.8×	47 1.0×	25 0.5×	41	375
Mark Angle Canada	13	88 1.3×	49 0.8×	40 0.7×	13 0.3×	12 0.3×	26	560
Deborah J. Dehring United States	12	64 0.9×	58 0.9×	77 1.3×	42 0.9×	17 0.4×	30	408
Riddhi Shah United States	11	85 1.3×	91 1.4×	113 1.9×	51 1.0×	11 0.2×	19	510
Apostolos Koroneos Greece	7	93 1.4×	50 0.8×	62 1.1×	14 0.3×	15 0.3×	10	428
G. Charissis Greece	9	36 0.5×	43 0.7×	137 2.3×	21 0.4×	12 0.3×	26	289
Stephen McCullough United States	10	25 0.4×	122 1.9×	76 1.3×	14 0.3×	61 1.3×	24	410
Tomotaka Yoshida Japan	11	62 0.9×	47 0.7×	41 0.7×	70 1.4×	7 0.2×	28	388
Rahul Vasudev United States	10	39 0.6×	104 1.6×	37 0.6×	11 0.2×	39 0.8×	54	270

Countries citing papers authored by Mark A. Gales

Since Specialization

Citations

This map shows the geographic impact of Mark A. Gales's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Gales with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Gales more than expected).

Fields of papers citing papers by Mark A. Gales

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Gales. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Gales. The network helps show where Mark A. Gales may publish in the future.

Co-authorship network of co-authors of Mark A. Gales

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Gales. A scholar is included among the top collaborators of Mark A. Gales based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Gales. Mark A. Gales is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gales, Mark A., et al.. (2022). “N-Acetylcysteine for Obsessive-Compulsive and Related Disorders in Children and Adolescents: A Review”. Annals of Pharmacotherapy. 57(7). 847–854. 6 indexed citations

Gales, Mark A., et al.. (2019). Inhaled Amphotericin B as Aspergillosis Prophylaxis in Hematologic Disease: An Update. SHILAP Revista de lepidopterología. 12. 2604567025–2604567025. 9 indexed citations

Gales, Mark A., et al.. (2018). Bumetanide for Autism Spectrum Disorder in Children: A Review of Randomized Controlled Trials. Annals of Pharmacotherapy. 53(5). 537–544. 26 indexed citations

Patatanian, Edna, et al.. (2018). Extended duration vancomycin in recurrentClostridium difficileinfection: a systematic review. Therapeutic Advances in Infectious Disease. 5(6). 111–119. 5 indexed citations

Walker, Cheri K., et al.. (2016). Increased Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in General Trauma Patients. Annals of Pharmacotherapy. 51(4). 323–331. 54 indexed citations

Walker, Cheri K. & Mark A. Gales. (2016). Melatonin Receptor Agonists for Delirium Prevention. Annals of Pharmacotherapy. 51(1). 72–78. 14 indexed citations

Gales, Mark A., et al.. (2015). Gabapentin in Alcohol Dependence. Journal of Pharmacy Technology. 31(4). 177–183. 1 indexed citations

Lê, Jennifer, Mark A. Gales, & Barry J Gales. (2014). Acetaminophen for Patent Ductus Arteriosus. Annals of Pharmacotherapy. 49(2). 241–246. 27 indexed citations

Gales, Barry J, et al.. (2010). Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for the Prevention of Migraines. Annals of Pharmacotherapy. 44(2). 360–366. 31 indexed citations

10.

Gales, Barry J & Mark A. Gales. (2007). Phosphodiesterase-5 Inhibitors for Lower Urinary Tract Symptoms in Men. Annals of Pharmacotherapy. 42(1). 111–115. 12 indexed citations

11.

Patatanian, Edna & Mark A. Gales. (2005). The Future of Statins: Alzheimer's Disease?. The Consultant Pharmacist. 20(8). 663–673. 2 indexed citations

12.

Gales, Mark A., et al.. (2000). Sorbitol Compared with Xylitol in Prevention of Dental Caries. Annals of Pharmacotherapy. 34(1). 98–100. 17 indexed citations

13.

Gales, Mark A., et al.. (2000). Sorbitol Compared with Xylitol in Prevention of Dental Caries. Annals of Pharmacotherapy. 34. 98–100. 2 indexed citations

14.

Gales, Mark A., et al.. (1999). Is Rectally Administered Cisapride an Effective Prokinetic Agent?. Annals of Pharmacotherapy. 33(11). 1217–1220. 4 indexed citations

15.

Thompson, Dennis F. & Mark A. Gales. (1996). Drug‐Induced Pure Red Cell Aplasia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(6). 1002–1008. 44 indexed citations

16.

Gales, Mark A., et al.. (1995). Rectally administered sodium polystyrene sulfonate. American Journal of Health-System Pharmacy. 52(24). 2813–2815. 3 indexed citations

17.

Gales, Mark A.. (1994). Oral Antihypertensives for Hypertensive Urgencies. Annals of Pharmacotherapy. 28(3). 352–358. 22 indexed citations

18.

Gales, Mark A., et al.. (1994). Combination sucralfate and histamine2-antagonist therapy.. PubMed. 28(5). 597–600. 1 indexed citations

19.

Gales, Barry J & Mark A. Gales. (1994). Erythema multiforme and angioedema with indapamide and sertraline. American Journal of Health-System Pharmacy. 51(1). 118–119. 8 indexed citations

20.

Gales, Barry J & Mark A. Gales. (1993). Granulocyte-Colony Stimulating Factor for Sulfasalazine-Induced Agranulocytosis. Annals of Pharmacotherapy. 27(9). 1052–1054. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact